Pharmaceuticals
10 CFOs in Pharmaceuticals
These ten finance executives hold or have held the chief financial officer role at pharmaceutical companies and at the country businesses of global drugmakers. A reader can learn how pharma CFOs approach product launches, R&D and business development investment, treasury and capital allocation, and finance for commercial operations.
Professionals to explore
01—10Aaron Rosenberg, CFA
LinkedInExperience: Chief Financial Officer · BeOne Medicines
Chief Financial Officer at BeOne Medicines since July 2024; the profile describes BeOne as a pharmaceutical manufacturing company focused on global cancer care. Before that he held finance leadership roles at Merck, including Vice President Finance, Merck Animal Health CFO (2015–2018), Senior Vice President, Corporate Strategy and Planning (2019–2021) and Senior Vice President Finance, Corporate Treasurer (2021–2024).
Amit Agarwal
LinkedInExperience: Executive Director Finance & Chief Financial Officer, Pfizer Ltd · Pfizer
Executive Director Finance & Chief Financial Officer, Pfizer Ltd at Pfizer since February 2024. Before Pfizer he held finance roles at Unilever from 2015 to 2024, including Finance Controller - Global Business Services (2016–2020), General Manager - Internal Audit (2020–2022) and General Manager Finance - Sales & Customer Development (2022–2024).
Colleen Tupper
LinkedInExperience: EVP & Chief Financial Officer · Collegium Pharmaceutical, Inc.
EVP & Chief Financial Officer at Collegium Pharmaceutical, Inc. since May 2021; the profile describes Collegium as a diversified specialty pharmaceutical company. Before that she was Senior Vice President & CFO, U.S. Business Unit at Takeda (2019–2021) and held vice president finance roles at Shire from 2015 to 2019, including Vice President, US Commercial Finance (2016–2019).
Katharina Russo
LinkedInExperience: Chief Financial Officer · Pharmacosmos Therapeutics Inc.
Chief Financial Officer at Pharmacosmos Therapeutics Inc. since April 2023; the profile describes Pharmacosmos as a privately held, Denmark-headquartered specialty pharmaceutical company focused on iron deficiency, with Pharmacosmos US as its US distribution arm. Before that she held finance roles at Novartis, including Head of Finance Cardio-Renal-Metabolic Business Unit (2017–2022) and Vice President Finance (2022–2023).
Michael Kalb
LinkedInExperience: EVP & Chief Financial Officer · Catalyst Pharmaceuticals, Inc.
EVP & Chief Financial Officer at Catalyst Pharmaceuticals, Inc. since January 2024. Earlier CFO roles include Chief Financial Officer and Chief Accounting Officer, Group V.P. at Taro Pharmaceuticals (2009–2016), SVP & Chief Financial Officer at Amarin Corporation (2016–2022), EVP & Chief Financial Officer at CinCor Pharma, Inc. (2022–2023) and Chief Financial Officer at Impel Pharmaceuticals (2023).
Priscila Plaza
LinkedInExperience: Chief Financial Officer · AstraZeneca
Chief Financial Officer at AstraZeneca since March 2022, based in São Paulo, Brazil, and also listed as Executive Controller at AstraZeneca from 2020 to 2022. Before AstraZeneca she was FP&A & Commercial Finance Executive Director Transition Leader at GE HealthCare (2015–2020) and CFO, Wind Latin America at GE (2010–2015).
Scott Reents
LinkedInExperience: Executive Vice President, Chief Financial Officer · AbbVie
Executive Vice President, Chief Financial Officer at AbbVie since November 2022, having held the Senior Vice President, Chief Financial Officer title earlier in 2022; the profile says he is responsible for AbbVie's global financial and business technology operations. Earlier AbbVie roles include Vice President, Tax (2013–2019) and Vice President, Tax and Treasury (2019–2022), and he joined Abbott's finance organization in 2008.
Sean Christie
LinkedInExperience: Chief Financial Officer · Alexion Pharmaceuticals, Inc.
Chief Financial Officer at Alexion Pharmaceuticals, Inc. since August 2021; the profile describes Alexion as a global biopharmaceutical company. Before that he held finance roles at AstraZeneca, including CFO Gulf States (2011–2012), Area Finance Director - Middle East & Africa (2012–2015), CFO China & Hong Kong (2015–2018) and VP Finance R&D (2018–2021).
Stephen Carey
LinkedInExperience: Senior Vice President, Finance and Chief Financial Officer · ANI Pharmaceuticals, Inc.
Senior Vice President, Finance and Chief Financial Officer at ANI Pharmaceuticals, Inc. since May 2016. Before that he held controller roles at Par Health from 2007 to 2015, from Vice President and Controller to Senior Vice President, Corporate Controller and Principal Accounting Officer, and earlier was Director of Finance, EUCAN at Merck (2005–2007).
Vaibhav Karandikar
LinkedInExperience: Chief Financial Officer · Sanofi India Limited
Chief Financial Officer at Sanofi India Limited since October 2020, after finance roles at the company dating from 2007. These include Associate Director Accounting & Direct tax (2007–2012), Director Accounting & Direct Tax (2012–2014), Director Accounting & Taxation (2014–2016) and Sr. Director Finance at Sanofi India Ltd (2016–2020).
Choose the right perspective
Match the person to your company's shape, since finance at a global drugmaker, a country affiliate and a specialty or emerging pharma company involves different trade-offs. For deal or capital questions, favor people whose notes show treasury, strategy or several CFO seats, and for commercial finance questions, favor those who led finance for a business unit or market.
Questions to take into the conversation
- 01How do you build the financial plan for a new product launch, and which assumptions do you revisit most often after launch?
- 02How do you decide how much to invest in R&D and business development versus returning capital to shareholders?
- 03How do you prepare the business and investors for a major product losing exclusivity?
Reaching CFOs in Pharmaceuticals
How can I contact one of these CFOs in Pharmaceuticals?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 10 companies, including BeOne Medicines; Pfizer and Collegium Pharmaceutical, Inc., based on profile data retrieved on September 28, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach CFOs in Pharmaceuticals?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal